Inventor
NABEL GARY
US20 patents
⚠️ This page may combine multiple inventors who share the name “NABEL GARY”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
US HEALTH
7 patentsUS9475862B2Oct 25, 2016
Neutralizing GP41 antibodies and their use
US HEALTH6 citations82
US10035845B2Jul 31, 2018
Neutralizing antibodies to HIV-1 and their use
US HEALTH2 citations72
US9738703B2Aug 22, 2017
Neutralizing antibodies to HIV-1 and their use
US HEALTH2 citations72
US7449190B2Nov 11, 2008
Assays for assembly of Ebola virus nucleocapsids
US HEALTH0 citations52
US10047148B2Aug 14, 2018
Neutralizing GP41 antibodies and their use
US HEALTH0 citations50
US9783595B2Oct 10, 2017
Neutralizing GP41 antibodies and their use
US HEALTH0 citations50
US8044185B2Oct 25, 2011
Conformationally stabilized HIV envelope immunogens and triggering HIV-I envelope to reveal cryptic V3-loop epitopes
US HEALTH0 citations48
DANA FARBER CANCER INST INC
4 patentsUS4559310ADec 17, 1985
Assay methods and systems utilizing mast cell clones
DANA FARBER CANCER INST INC33 citations92
US4722998AFeb 2, 1988
Method of producing lymphocyte growth factors
DANA FARBER CANCER INST INC13 citations73
US4720482AJan 19, 1988
Pharmaceutical compositions containing one or more lymphocyte growth factors
DANA FARBER CANCER INST INC8 citations73
US4613459ASep 23, 1986
Lymphocyte growth factor
DANA FARBER CANCER INST INC14 citations73
SANOFI SA
2 patentsSULLIVAN NANCY
2 patentsUS9012618B2Apr 21, 2015
Nucleic acids encoding modified Ebola virus glycoproteins with diminished cytotoxicity while retaining native antigenic structures
SULLIVAN NANCY5 citations81
US8101739B2Jan 24, 2012
Recombinant expression vectors comprising a human codon-optimized marburg virus (MARV) angola glycoprotein gene insert and method of immunization employing said vector
SULLIVAN NANCY10 citations81